PRTG

Portage Biotech (PRTG)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRTG
DataOraFonteTitoloSimboloCompagnia
12/04/202414:01GlobeNewswire Inc.Portage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesNASDAQ:PRTGPortage Biotech Inc
26/03/202413:01GlobeNewswire Inc.Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesNASDAQ:PRTGPortage Biotech Inc
08/03/202423:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
08/03/202423:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
28/02/202423:10GlobeNewswire Inc.Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateNASDAQ:PRTGPortage Biotech Inc
14/02/202421:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRTGPortage Biotech Inc
04/01/202414:00GlobeNewswire Inc.Portage Biotech Reports Business and Strategic UpdateNASDAQ:PRTGPortage Biotech Inc
01/12/202322:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRTGPortage Biotech Inc
08/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRTGPortage Biotech Inc
06/11/202314:01GlobeNewswire Inc.Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:PRTGPortage Biotech Inc
31/10/202321:05Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PRTGPortage Biotech Inc
31/07/202323:12Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PRTGPortage Biotech Inc
21/06/202312:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
13/10/202212:01Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:PRTGPortage Biotech Inc
08/08/202212:26TipRanksPortage Biotech Inc (PRTG) Receives a Buy from H.C. WainwrightNASDAQ:PRTGPortage Biotech Inc
01/08/202223:14Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRTGPortage Biotech Inc
08/07/202212:25TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Aeterna Zentaris (AEZS), Portage Biotech Inc (PRTG)NASDAQ:PRTGPortage Biotech Inc
04/04/202212:15TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:PRTGPortage Biotech Inc
04/03/202212:05Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:PRTGPortage Biotech Inc
26/10/202116:13TipRanks2 ‘Strong Buy’ Stocks Oppenheimer Predicts Will Surge at Least 50%NASDAQ:PRTGPortage Biotech Inc
24/06/202123:28Edgar (US Regulatory)Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)NASDAQ:PRTGPortage Biotech Inc
09/03/202112:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRTGPortage Biotech Inc
08/03/202123:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:PRTGPortage Biotech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRTG
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network